Search

everythinglearnresearchcommunity

for

Search:↓

Deuruxolitinib significantly improves hair satisfaction in severe alopecia areata patients.

RC48 shows promise for treating certain advanced cancers, but more research is needed.

Baricitinib works better than methotrexate for severe alopecia areata.

Entospletinib effectively prevents eye and skin GVHD in mice.

Contact immunotherapy can cause vitiligo in patients with autoimmune conditions.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

Weekly bicalutamide is safe and effective, with 50 mg/week recommended.

Bicalutamide added no extra benefit over minoxidil alone for female-pattern hair loss.

Deucravacitinib helped a man regrow hair significantly.

Trastuzumab may cause tufted hair folliculitis as a side effect.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

The combination treatment reduced prostate size and improved testosterone deficiency symptoms but was less effective for sexual function.

Preventive measures and effective management are crucial for reducing skin side effects in cancer treatment.

Ruxolitinib cream may help treat severe hair loss in children.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

Vemurafenib can cause scalp issues but can be managed without changing the dose.

Pentoxifylline alone and combined with triamcinolone acetonide is effective for treating localized alopecia areata, with the combination showing the highest effectiveness.

Upadacitinib improved multiple immune-related conditions in one patient.

Combining gemcitabine with paclitaxel is more effective than with pemetrexed for advanced lung cancer.

Trametinib can effectively treat severe kaposiform lymphangiomatosis when other treatments fail.

Etanercept is safe and may help improve hidradenitis suppurativa, but more research is needed.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

The combination therapy is safe and more effective for treating pediatric facial and cervical vitiligo.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

Microneedle arrays deliver botulinum toxin effectively for sweat suppression, similar to injections.

FUE with topical CBD effectively treats stable vitiligo.